- Types of Eczema
- Child Eczema
- Causes & Triggers
- Living with Eczema
- Eczema Products
- Get Involved
A clinical trial is a research study in human volunteers used to determine whether new drugs or treatments are safe and effective. Clinical testing is preceded by extensive laboratory research, and is normally done in five phases. Participants can help themselves and others by contributing to medical research.
The following information is presented as a service to those who might be interested in participating in clinical research trials studying atopic dermatitis/eczema. Please click on the title of the research study for more information. Please feel free to contact the NEA office for more information.
Postdate: November 16, 2016
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of XXXXX to the Marketed Product XXXXX Cream, XXXXX in the Treatment of Mild to Moderate Atopic Dermatitis
Postdate: September 1, 2016
A Double-Blind, Randomized, Parallel-Group, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Bioequivalence of a Generic XXXX and Reference Listed XXXX and Compare Both Active Treatments to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis
Postdate: June 22, 2016
Atopic Dermatitis (Eczema) Research Study
Postdate: May 6, 2016
A Randomized, Double-Blind, Vehicle-Controlled Ascending Multiple Dose and Clinical Proof–of-Concept Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VTP-38543 in Adult Patients with Mild to Moderate Atopic Dermatitis
Postdate: April 7, 2016
Protobol 14V-MC-JAHG(b) A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis
Postdate: September 24, 2015
The primary objective for this study is to evaluate the safety of lebrikizumab compared with Topical Corticosteroids (TCS) alone in patients with persistent moderate to severe atopic dermatitis (AD) that is inadequately controlled with topical corticosteroids (TCS)
Postdate: September 24, 2015
Randomized, double-blind, placebo controlled study will evaluate the efficacy of lebrikizumab administered subcutaneously (SC) in adult patients with moderate to severe atopic dermatitis (AD) who are inadequately controlled by topical corticosteroids (TCS)
Postdate: August 13, 2015
Non Drug Study to Investigate Biological Differences Between Normal vs Atopic Dermatitis Human Tissues
Postdate: June 1, 2015
To Compare the Safety and Efficacy of Orally Administered DS107G Capsules vs. Placebo
Postdate: October 22, 2014
Dupilumab and Immune Responses in Adults with Atopic Dermatitis
Postdate: August 26, 2014
Systemic Therapies for Pediatric Atopic Dermatitis
Postdate: August 22, 2014
Studies of Skin Microbes in Healthy People and People With Skin Conditions
Postdate: August 15, 2014
Interferon Responses in Eczema Herpeticum (EH) (IFN)
Postdate: July 14, 2014
The Effect of Emollient Therapy on the Skin Barrier (EES)
Postdate: May 1, 2014
Topical, Steroid-Free Investigational Medication for Eczema in Children and Adolescents
Postdate: February 7, 2014
A Study for Patients with Eczema who Find Topical Treatments Fail to Control or Cause an Allergic Reaction
Postdate: January 21, 2014
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study Investigating the Efficacy, Safety, Serum Concentration, and Biomarker Profile of Dupilumab Administered to Adult Patients with Moderate-to-Severe Atopic Dermatitis
Postdate: January 21, 2014
Phase II Study to Determine the Safety, Tolerability, Pharmacodynamics and Clinical Efficacy of ILV-094
Postdate: June 21, 2012
Mood Factors/Itch Quality of Life Study
Postdate: September 8, 2011
New Atopic Dermatitis Clinical Trial Protocol R668-AD-0914 – Regeneron Pharmaceuticals, Inc.
Postdate: March 10, 2011
Online Health Survey of Patients with Vitiligo
Postdate: March 9, 2011
How People Adjust to Eczema
The National Eczema Association (NEA) is committed to improving patients’ quality of life through research, education, and support. NEA does not provide medical advice to patients but provides information to help them better understand their health, diagnosed conditions and the current range of approaches related to eczema treatment, prevention and supportive care. NEA urges patients to consult with a qualified physician for diagnosis and treatment.
As part of the fulfillment of its mission, NEA provides information to its constituents regarding clinical research trial availability and participation. NEA does not recruit patients for clinical trials and NEA does not conduct clinical trials. Below is a notice for a research study that we thought might be of interest to you. NEA is providing this information as a service. NEA does not endorse the study, which is being conducted at locations and under protocols that are not monitored or reviewed by NEA. Accordingly, NEA cannot be held responsible for anything that may occur in connection with the study. NEA may be reimbursed by the sponsor of the study for costs incurred in connection with notifying NEA constituents of the availability of the study. Should you have any questions regarding the study, please contact the study sponsor.
NEA respects your privacy and does not release your private information to any outside individuals, companies or organizations. Please see complete NEA Clinical Trials Policy here.
Clinicaltrials.gov is a registry of federally or privately supported clinical trials conducted in the United States and around the world.